References
- WoodheadMCommunity-acquired pneumonia in Europe: causative pathogens and resistance patternsEur Respir J Suppl20023620s27s12168744
- American Thoracic Society, European Respiratory SocietyStandards for the Diagnosis and Management of Patients with COPD http://www.thoracic.org/clinical/copd-guidelines/resources/copddoc.pdf. Accessed January 13, 2011.
- ScheldWMMaintaining fluoroquinolones class effectiveness: review of influencing factorsEmerg Infect Dis200391912533274
- LonksJRGarauJMedeirosAAImplications of antimicrobial resistance in the empirical treatment of community-acquired respiratory tract infections: the case of macrolidesJ Antimicrob Chemother200250Suppl S2879212556438
- BlondeauJMA review of the comparative in vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolonesJ Antimicrob Chemother199943Suppl B11110382869
- WoodheadMBlasiFEwigSGuidelines for the management of adult lower respiratory tract infectionsEur Respir J2005261138118016319346
- LiuYDiagnosis and treatment guideline for community-acquired pneumoniaChin J Tuberc Respir Dis200629654
- YaoWDiagnosis and treatment guideline for chronic obstructive pulmonary diseaseChin J Tuberc Respir Dis20073015
- LiuLYLandenHTreatment of respiratory tract infections with moxifloxacin: results of postmarketing surveillance in ChinaInt J Clin Pract2007611509151517635617